Tevogen highlights COVID-19 treatment data for immunocompromised patients
Go back to Tevogen highlights COVID-19 treatment data for immunocompromised patients| (NASDAQ: TVGN) | Delayed: 10.47 -1.2 (10.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.67 | 52 Week High | $ | |||
| Open | $12.00 | 52 Week Low | $ | |||
| Day High | $12.03 | P/E | N/A | |||
| Day Low | $9.92 | EPS | $ | |||
| Volume | 23,005 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 5,137 | |||||

